Valuation: SMS Pharmaceuticals Limited

Market Cap 35.11B 368M 319M 298M 272M 513M 521M 3.49B 1.37B 17.56B 1.38B 1.35B 58.49B P/E 2024
30.3x
P/E 2025 27.3x
Enterprise Value 37.8B 396M 343M 321M 293M 552M 561M 3.76B 1.48B 18.91B 1.49B 1.46B 62.98B EV / Sales 2024
2.47x
EV / Sales 2025 2.75x
Free-Float
23.47%
Yield 2024
0.22%
Yield 2025 0.19%
1 day-1.64%
1 week-0.53%
Current month-0.53%
1 month-8.64%
3 months-10.68%
6 months+16.15%
Current year+19.81%
1 week 355.5
Extreme 355.5
381.85
1 month 355.5
Extreme 355.5
411.3
Current year 293.15
Extreme 293.15
447.8
1 year 218.61
Extreme 218.61
447.8
3 years 111.85
Extreme 111.85
447.8
5 years 54.55
Extreme 54.55
447.8
10 years 24
Extreme 24
447.8
Manager TitleAgeSince
Chief Executive Officer 66 29/08/1990
Director of Finance/CFO - 12/09/2017
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 66 29/08/1990
Director/Board Member 38 04/06/2020
Director/Board Member 48 28/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%-0.53%+65.80%+194.22% 372M
-0.03%-2.32%+22.53%+68.67% 49.03B
-1.14%+9.22%+60.80%+124.81% 42.33B
+0.27%-0.37%-1.22%+15.93% 12.43B
+0.43%-0.69%+19.53%+69.15% 11.68B
-0.19%+0.19%+30.98%+140.74% 9.12B
+3.81%+7.21%+22.04%+37.90% 7.15B
+1.62%+3.49%+41.67%-13.45% 7.09B
-1.22%+0.78%+11.47%+171.70% 6.76B
+0.03%+8.55%-24.59%+30.34% 5.95B
Average +0.19%+2.38%+24.90%+84.00% 15.19B
Weighted average by Cap. -0.09%+1.73%+30.17%+82.47%

Financials

2024 2025
Net sales 7.09B 74.37M 64.38M 60.18M 55M 104M 105M 706M 277M 3.55B 279M 273M 11.82B 7.83B 82.07M 71.05M 66.41M 60.7M 114M 116M 779M 306M 3.92B 308M 301M 13.04B
Net income 498M 5.22M 4.52M 4.23M 3.86M 7.28M 7.39M 49.57M 19.45M 249M 19.62M 19.19M 830M 691M 7.25M 6.28M 5.87M 5.36M 10.1M 10.26M 68.78M 26.99M 346M 27.22M 26.63M 1.15B
Net Debt 2.45B 25.65M 22.21M 20.76M 18.97M 35.75M 36.31M 243M 95.51M 1.22B 96.32M 94.22M 4.08B 2.69B 28.23M 24.44M 22.85M 20.88M 39.35M 39.96M 268M 105M 1.35B 106M 104M 4.49B
Logo SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Employees
1,470
Date Price Change Volume
10/08/26 ₹371.90 -1.64% 109,735
07/08/26 ₹378.10 +5.85% 553,999
06/08/26 ₹357.20 -2.02% 179,849
05/08/26 ₹364.55 +0.29% 141,953
04/08/26 ₹363.50 -0.01% 236,700

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SMSPHARMA Stock